PACB logo

Pacific Biosciences Of California (PACB) Return On Assets

Annual ROA

-17.46%
-0.81%-4.86%

31 December 2023

PACB ROA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly ROA

-23.82%
-0.73%-3.16%

30 September 2024

PACB Quarterly ROA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PACB ROA Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-4.9%-42.2%
3 y3 years-266.9%-576.7%
5 y5 years+73.2%+64.5%

PACB ROA High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-266.9%at low-576.7%at low
5 y5 years-266.9%+73.2%-312.3%+64.5%
alltimeall time-266.9%+78.7%-312.3%+76.9%

Pacific Biosciences Of California ROA History

DateAnnualQuarterly
Sept 2024
-
-23.82%(+3.2%)
June 2024
-
-23.09%(+40.9%)
Mar 2024
-
-16.39%(-2.1%)
Dec 2023
-17.46%(+4.9%)
-16.75%(0.0%)
Sept 2023
-
-16.75%(-3.4%)
June 2023
-
-17.34%(+0.5%)
Mar 2023
-
-17.25%(+3.2%)
Dec 2022
-16.65%(+11.2%)
-16.71%(+8.0%)
Sept 2022
-
-15.47%(+36.9%)
June 2022
-
-11.30%(+9.3%)
Mar 2022
-
-10.34%(-20.6%)
Dec 2021
-14.97%(-243.1%)
-13.03%(+270.2%)
Sept 2021
-
-3.52%(-68.8%)
June 2021
-
-11.27%(-8.1%)
Mar 2021
-
-12.27%(-209.4%)
Dec 2020
10.46%(-119.8%)
11.22%(-151.3%)
Sept 2020
-
-21.87%(-21.8%)
June 2020
-
-27.95%(-5.9%)
Mar 2020
-
-29.69%(-42.1%)
Dec 2019
-52.87%(-19.0%)
-51.27%(-23.6%)
Sept 2019
-
-67.12%(+2.6%)
June 2019
-
-65.43%(+0.2%)
Mar 2019
-
-65.27%(+0.7%)
Dec 2018
-65.25%(-0.2%)
-64.81%(+9.1%)
Sept 2018
-
-59.39%(+2.7%)
June 2018
-
-57.83%(-3.4%)
Mar 2018
-
-59.88%(-2.1%)
Dec 2017
-65.39%
-61.19%(+2.8%)
Sept 2017
-
-59.52%(+5.7%)
June 2017
-
-56.29%(+3.6%)
DateAnnualQuarterly
Mar 2017
-
-54.36%(+5.4%)
Dec 2016
-55.30%(+122.9%)
-51.57%(+24.1%)
Sept 2016
-
-41.54%(+39.6%)
June 2016
-
-29.75%(+10.7%)
Mar 2016
-
-26.88%(-5.3%)
Dec 2015
-24.81%(-51.1%)
-28.38%(-36.8%)
Sept 2015
-
-44.87%(-14.0%)
June 2015
-
-52.16%(-3.8%)
Mar 2015
-
-54.24%(+6.8%)
Dec 2014
-50.78%(-14.9%)
-50.78%(+7.2%)
Sept 2014
-
-47.37%(-13.4%)
June 2014
-
-54.68%(-0.1%)
Mar 2014
-
-54.73%(-4.4%)
Dec 2013
-59.65%(+9.9%)
-57.23%(-3.7%)
Sept 2013
-
-59.41%(-0.2%)
June 2013
-
-59.55%(+5.9%)
Mar 2013
-
-56.24%(+2.5%)
Dec 2012
-54.29%(+30.0%)
-54.87%(+11.2%)
Sept 2012
-
-49.33%(+4.5%)
June 2012
-
-47.21%(+10.0%)
Mar 2012
-
-42.90%(+2.1%)
Dec 2011
-41.75%(-39.4%)
-42.01%(-17.1%)
Sept 2011
-
-50.68%(-14.9%)
June 2011
-
-59.56%(-10.7%)
Mar 2011
-
-66.73%(-17.9%)
Dec 2010
-68.90%(-15.9%)
-81.29%(-21.1%)
Sept 2010
-
-103.00%(+13.1%)
June 2010
-
-91.05%(+11.0%)
Mar 2010
-
-82.02%(+57.7%)
Dec 2009
-81.89%(+111.7%)
-52.02%
Dec 2008
-38.68%
-

FAQ

  • What is Pacific Biosciences of California annual return on assets?
  • What is the all time high annual ROA for Pacific Biosciences of California?
  • What is Pacific Biosciences of California annual ROA year-on-year change?
  • What is Pacific Biosciences of California quarterly return on assets?
  • What is the all time high quarterly ROA for Pacific Biosciences of California?
  • What is Pacific Biosciences of California quarterly ROA year-on-year change?

What is Pacific Biosciences of California annual return on assets?

The current annual ROA of PACB is -17.46%

What is the all time high annual ROA for Pacific Biosciences of California?

Pacific Biosciences of California all-time high annual return on assets is 10.46%

What is Pacific Biosciences of California annual ROA year-on-year change?

Over the past year, PACB annual return on assets has changed by -0.81% (-4.86%)

What is Pacific Biosciences of California quarterly return on assets?

The current quarterly ROA of PACB is -23.82%

What is the all time high quarterly ROA for Pacific Biosciences of California?

Pacific Biosciences of California all-time high quarterly return on assets is 11.22%

What is Pacific Biosciences of California quarterly ROA year-on-year change?

Over the past year, PACB quarterly return on assets has changed by -7.07% (-42.21%)